Shares of Senseonics Holdings, Inc. (NYSEAMERICAN:SENS) have earned a consensus rating of “Hold” from the eight brokerages that are covering the firm, MarketBeat Ratings reports. Two analysts have rated the stock with a sell recommendation, three have issued a hold recommendation and three have issued a buy recommendation on the company. The average twelve-month target price among brokerages that have issued ratings on the stock in the last year is $3.88.
SENS has been the subject of a number of analyst reports. HC Wainwright initiated coverage on Senseonics in a report on Thursday, August 19th. They issued a “buy” rating and a $6.00 price target for the company. Zacks Investment Research cut Senseonics from a “buy” rating to a “hold” rating in a report on Wednesday, November 17th. Finally, Colliers Securities restated a “buy” rating and issued a $4.00 price target on shares of Senseonics in a report on Tuesday, August 10th.
In other Senseonics news, COO Mukul Jain sold 100,000 shares of the business’s stock in a transaction dated Tuesday, November 16th. The shares were sold at an average price of $3.70, for a total transaction of $370,000.00. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Francine Kaufman sold 20,998 shares of the business’s stock in a transaction dated Tuesday, November 16th. The shares were sold at an average price of $3.70, for a total transaction of $77,692.60. The disclosure for this sale can be found here. Corporate insiders own 5.60% of the company’s stock.
Shares of NYSEAMERICAN:SENS traded down $0.11 during trading on Thursday, reaching $3.27. 8,444,483 shares of the stock were exchanged, compared to its average volume of 28,353,381. Senseonics has a 12-month low of $0.35 and a 12-month high of $5.56. The stock has a market capitalization of $1.46 billion, a P/E ratio of -2.29 and a beta of 0.49.
Senseonics (NYSEAMERICAN:SENS) last issued its earnings results on Tuesday, November 9th. The company reported $0.08 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.04) by $0.12. Research analysts expect that Senseonics will post -0.1 EPS for the current year.
Senseonics Holdings, Inc engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.
Further Reading: How to invest in blue-chip stocks
Receive News & Ratings for Senseonics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Senseonics and related companies with MarketBeat.com's FREE daily email newsletter.